Short Interest in Takara Bio Inc. (OTCMKTS:TKBIF) Drops By 40.7%

Takara Bio Inc. (OTCMKTS:TKBIFGet Free Report) was the target of a significant decline in short interest in October. As of October 31st, there was short interest totalling 14,400 shares, a decline of 40.7% from the October 15th total of 24,300 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Takara Bio Price Performance

OTCMKTS TKBIF remained flat at $23.20 during trading hours on Friday. Takara Bio has a one year low of $23.20 and a one year high of $23.20. The company has a 50 day simple moving average of $23.20 and a 200 day simple moving average of $23.20.

About Takara Bio

(Get Free Report)

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.

Further Reading

Receive News & Ratings for Takara Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takara Bio and related companies with MarketBeat.com's FREE daily email newsletter.